Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Hormone therapy for trans individuals is effective and generally safe in the short term.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.